Becton, Dickinson and Company SG&A decreased by 12.9% to $1.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $1.12B to $1.21B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 2.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
Detailed definition
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Peer comparison
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
selling_general_and_administrativeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20B | $1.22B | $1.19B | $1.19B | $1.15B | $1.18B | $1.19B | $1.21B | $1.19B | $1.14B | $1.21B | $1.19B | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| QoQ Change | — | +1.8% | -3.0% | +0.6% | -3.6% | +3.0% | +0.3% | +1.5% | -1.2% | -4.5% | +6.7% | -1.6% | +0.3% | +4.9% | +5.0% | -15.3% | +18.2% | +15.4% | -8.5% | -12.9% |
| YoY Change | — | — | — | — | -4.3% | -3.2% | +0.2% | +1.1% | +3.6% | -3.9% | +2.2% | -1.0% | +0.5% | +10.4% | +8.7% | -6.4% | +10.4% | +21.4% | +5.7% | +8.6% |
Product Breakdown
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Shipping and Handling | $1.21B | $1.19B | $1.20B | $1.32B | $1.12B | $1.32B | $1.39B | $1.21B |
| Total | $1.21B | $1.19B | $1.20B | $1.32B | $1.12B | $1.32B | $1.39B | $1.21B |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| BioPharma Systems | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| Connected Care | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| Interventional | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| Life Sciences | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| Medical | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| Medical Essentials | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
| Total | $1.20B | $1.26B | $1.32B | $1.12B | $1.32B | $1.52B | $1.39B | $1.21B |
BioPharma Systems, Connected Care, Interventional, Life Sciences, Medical, Medical Essentials were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
SG&A at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's sg&a?
- Becton, Dickinson and Company (BDX) reported sg&a of $1.21B in Q1 2026.
- How has Becton, Dickinson and Company's sg&a changed year-over-year?
- Becton, Dickinson and Company's sg&a increased by 8.6% year-over-year, from $1.12B to $1.21B.
- What is the long-term trend for Becton, Dickinson and Company's sg&a?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's sg&a has grown at a 2.8% compound annual growth rate (CAGR), from $4.72B to $5.28B.
- What does sg&a mean?
- The day-to-day costs of running the business and marketing its products.